Healthcare is Human Act Introduced to Support Healthcare Workers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 13 2026
0mins
Should l Buy FIGS?
Source: Yahoo Finance
- Legislative Background: The bipartisan Healthcare is Human Act, co-sponsored by Reps. Claudia Tenney and Steven Horsford, aims to provide a federal tax credit of up to $6,000 annually to healthcare professionals, directly addressing low pay and staffing shortages that contribute to burnout and turnover in the healthcare sector.
- Healthcare Shortage Reality: According to the latest report from the federal Health Services and Resources Administration, there are over 8,200 primary care, 7,200 dental, and 6,600 mental health shortage areas in the U.S., highlighting the urgent need for healthcare services, and the implementation of this legislation will help attract more professionals to these critical fields.
- Policy Impact: This act not only provides financial incentives for current healthcare workers but also aims to improve medical services in rural areas and those serving veterans, ensuring these communities receive timely care and ultimately enhancing overall public health outcomes.
- Industry Response: FIGS CEO Trina Spear stated that this legislation is historic, reflecting recognition and support for healthcare professionals, emphasizing the importance of the healthcare industry to society, and hopes to enhance the respect and value of healthcare workers through this initiative.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FIGS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FIGS
Wall Street analysts forecast FIGS stock price to fall
5 Analyst Rating
2 Buy
2 Hold
1 Sell
Hold
Current: 15.370
Low
7.50
Averages
10.70
High
15.00
Current: 15.370
Low
7.50
Averages
10.70
High
15.00
About FIGS
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle brand. The Company sells products designed to serve the particular needs of healthcare professionals primarily through its direct-to-consumer (DTC) digital platform, consisting of its Website, mobile app and B2B business (TEAMS). Its offerings include scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. Its non-scrubwear products are designed as an integrated system that complements its scrubwear and are comprised of base layer and outer layer products. Its underscrubs include sports bras, performance leggings, performance tops and super-soft pima cotton tops. Its under underscrubs include several styles of underwear. Its outer layer products include footwear, lab coats, and a variety of vests, jackets, and fleeces. The Company also offers necessities, such as scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Fluence Energy Surge: Fluence Energy's stock soared nearly 30% after its fiscal second-quarter EBITDA exceeded Wall Street estimates, following a prior session surge of about 40%, indicating strong market confidence in its growth potential and attracting more investor interest.
- Corpay Raises Guidance: Corpay shares jumped 10% after the company raised its full-year earnings guidance to a range of $26.30 to $27.10 per share, surpassing analyst expectations of $26.05, reflecting robust performance in the corporate payments sector and potentially increasing market share.
- Akamai Technologies Rises: Akamai's stock surged 20% after securing an $1.8 billion commitment from a leading U.S. frontier model provider for its Cloud Infrastructure Services, indicating strong demand in the market, while also reporting a first-quarter adjusted earnings beat that bolstered investor confidence.
- Upwork Restructuring Impact: Upwork's shares tumbled 21% following its announcement of a 24% workforce reduction to ensure profitability, despite slightly lower-than-expected first-quarter earnings and revenue, which may affect its future competitive position and investor sentiment.
See More
- Earnings Beat: Figs reported Q1 earnings of $0.03 per share and sales of $159.9 million, surpassing analyst expectations of $0.01 and $152.5 million, indicating strong performance in the medical apparel sector.
- Strong Sales Growth: Despite a robust 28% sales growth in Q1, with scrubwear up 27% and non-scrubwear up 31%, investor disappointment over future guidance led to a significant stock price drop.
- Cost Management: Figs managed to keep operating costs up only 23%, slower than sales growth, while gross margin slightly improved to 65.09%, showcasing effective cost control, although overall profitability remains a concern.
- Conservative Guidance: Figs' guidance for 2026 sales growth of only 14% to 16% is lower than the Q1 growth rate, though it exceeds Wall Street's expectation of 12%, yet investor concerns about future growth prospects have resulted in substantial stock volatility.
See More
- Akamai Stock Surge: Shares of Akamai Technologies soared 27% after a leading U.S. frontier model provider committed to a $1.8 billion investment over seven years for its Cloud Infrastructure Services, enhancing market confidence and potentially driving future revenue growth.
- CoreWeave Revenue Guidance Miss: CoreWeave's second-quarter revenue guidance of $2.45 billion to $2.6 billion, with a midpoint of $2.53 billion, fell short of Wall Street's $2.69 billion expectation, resulting in a 7% stock decline, reflecting market concerns about its growth outlook.
- Microchip Earnings Beat: Microchip Technology's stock rose 3% following a fiscal fourth-quarter report that exceeded earnings and revenue expectations, with projected first-quarter revenue between $1.44 billion and nearly $1.47 billion, indicating strong performance in the semiconductor sector.
- Upwork Restructuring Plan: Upwork's announcement of a 24% workforce reduction to maintain profitability led to a 23% drop in its stock price, despite slightly lower-than-expected first-quarter earnings and revenue, showcasing the company's strategic response to evolving market conditions.
See More
- Significant Revenue Growth: FIGS reported Q1 net revenues of $159.9 million, reflecting a 28% year-over-year increase that exceeded market expectations, indicating strong momentum in customer growth and market expansion, with full-year revenue growth outlook raised to 14%-16%.
- Customer Base Expansion: The company surpassed 3 million active customers for the first time, demonstrating significant progress in attracting new customers and improving retention, further solidifying its leadership position in the medical apparel market.
- International Market Expansion: FIGS saw a 50% year-over-year increase in international net revenue, now operating in 85 international markets after successfully opening 15 new markets in Europe and an additional 12 in Asia Pacific, showcasing the effectiveness of its globalization strategy and strong market demand.
- Profitability Improvement: The adjusted EBITDA margin for Q1 increased to 8.7%, up from 7.3% last year, while the company plans to continue enhancing operating margins in the coming quarters, reflecting strong profitability and sustainable growth potential.
See More
- Market Volatility: Doubts surrounding the Iran deal led to volatility in the stock market on Thursday, with major indices experiencing declines, reflecting investor sensitivity to geopolitical risks and uncertainty.
- Tech Stocks Resilience: Despite the overall market pressure, Nvidia and Tesla showed strong performance, indicating investor confidence in the long-term growth potential of these companies, which may attract more capital into the tech sector.
- Earnings Movers: CoreWeave, Rocket Lab, Cloudflare, and IREN's earnings reports became focal points for the market, with investors closely monitoring their performance to assess future growth prospects and competitive positioning.
- Jobs Report Anticipation: The market is set to receive a new jobs report, with analysts expecting it to provide crucial signals regarding economic recovery, which could further influence investor decisions and market trends.
See More
- Akamai Stock Surge: Akamai Technologies shares surged 25% after announcing a $1.8 billion seven-year contract with a leading U.S. frontier model provider, indicating strong demand for its Cloud Infrastructure Services and likely boosting future revenues significantly.
- Gen Digital's Positive Guidance: Gen Digital's stock rose 8% following its current-quarter and full-year revenue guidance that exceeded analysts' expectations, suggesting robust performance in the software market that could drive future stock price increases.
- Trade Desk Stock Plummet: Trade Desk's shares plummeted 14% as its current-quarter revenue guidance fell short of analyst expectations, highlighting intensified competition in the advertising technology sector that may impact the company's future market share.
- Gilead's Adjusted Outlook: Gilead Sciences shares dropped 3% after projecting a full-year adjusted loss of $1.05 to $0.65 per share, reflecting increased research and development and financing costs, which could negatively affect investor confidence.
See More











